Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis

Translational Neurodegeneration

Shyamal Peddada⁴  Deborah S Cousins¹  Michele A Justice¹  Anna J Ciesielski-Jones¹  Xuemei Huang²  Rui Liu³  Yi Lu¹  Wen Zhang³  Edward J Zhao³  Honglei Chen³ 

[1] Social & Scientific Systems, Inc., Durham, North Carolina, USA;Departments of Neurology, Radiology, Neurosurgery, Pharmacology, & Kinesiology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA;Epidemiology Branch, National Institute of Environmental Health Sciences, 111 T.W. Alexander Dr., P.O. Box 12233, Mail drop A3-05, Research Triangle Park, NC 27709, USA;Biostatistics Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA

关键词: Natural history;    Prevalence;    Meta-analysis;    Nonmotor symptoms;    Parkinson’s disease;   

Others  :  1138669
DOI  :  10.1186/2047-9158-4-1

 received in 2014-10-13, accepted in 2015-01-05,  发布年份 2015

【 摘 要 】

Background

Nonmotor symptoms are common among patients with Parkinson’s disease (PD) and some may precede disease diagnosis.

Methods

We conducted a meta-analysis on the prevalence of selected nonmotor symptoms before and after PD diagnosis, using random-effect models. We searched PubMed (1965 through October/November 2012) for the following symptoms: hyposmia, constipation, rapid eye movement sleep behavior disorder, excessive daytime sleepiness, depression, and anxiety. Eligible studies were publications in English with original data on one or more of these symptoms.

Results

The search generated 2,373 non-duplicated publications and 332 met the inclusion criteria, mostly (n = 320) on symptoms after PD diagnosis. For all symptoms, the prevalence was substantially higher in PD cases than in controls, each affecting over a third of the patients. Hyposmia was the most prevalent (75.5% in cases vs. 19.1% in controls), followed by constipation (50% vs. 17.7%), anxiety (39.9% vs. 19.1%), rapid eye movement sleep behavior disorder (37.0% vs. 7.0%), depression (36.6% vs. 14.9%), and excessive daytime sleepiness (33.9% vs. 10.5%). We observed substantial heterogeneities across studies and meta-regression analyses suggested that several factors might have contributed to this. However, the prevalence estimates were fairly robust in several sensitivity analyses. Only 20 studies had data on any symptoms prior to PD diagnosis, but still the analyses revealed higher prevalence in future PD cases than in controls.

Conclusion

These symptoms are common among PD patients both before and after diagnosis. Further studies are needed to understand the natural history of nonmotor symptoms in PD and their etiological and clinical implications.

【 授权许可】

   
2015 Chen et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Soh SE, Morris ME, McGinley JL: Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011, 17(1):1-9.
• [2]Lang AE: A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011, 26(5):775-83.
• [3]Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al.: Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63(2):167-73.
• [4]Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, et al.: Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007, 22(11):1581-6.
• [5]Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, et al.: Medical records documentation of constipation preceding Parkinson disease: A case–control study. Neurology 2009, 73(21):1752-8.
• [6]Gao X, Chen H, Schwarzschild MA, Ascherio A: A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011, 174(5):546-51.
• [7]Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, et al.: Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010, 25(13):2105-13.
• [8]Fang F, Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, et al.: Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010, 25(9):1157-62.
• [9]Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A: Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003, 18(6):646-51.
• [10]Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF: REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010, 75(6):494-9.
• [11]Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J: Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72(15):1296-300.
• [12]Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al.: Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005, 65(9):1442-6.
• [13]Gao J, Huang X, Park Y, Hollenback A, Blair A, Schatzkin A, et al.: Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 2011, 173(9):1032-8.
• [14]Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Tredici KD: Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Movement Disorders 2006, 21(12):2042-51.
• [15]Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbot R, et al.: Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications. Environ Health Perspect 2013, 121(11–12):1245-52.
• [16]Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al.: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24(11):1641-9.
• [17]Herting B, Schulze S, Reichmann H, Haehner A, Hummel T: A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008, 255(3):367-70.
• [18]Herlofson K, Ongre SO, Enger LK, Tysnes OB, Larsen JP: Fatigue in early Parkinson's disease. Minor inconvenience or major distress? Eur J Neurol 2012, 19(7):963-8.
• [19]Gupta A, Bhatia S: Psychological functioning in patients with Parkinson's disease. Parkinsonism Relat Disord 2000, 6(3):185-90.
• [20]Chew V: Point Estimation of the Parameter of the Binomial Distribution. The American Statistician 1971, 25(5):47-50.
• [21]Lipsey MW, Wilson DB: Practical Meta-Analysis. London: SAGE Publicaitons; 2000.
• [22]Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-58.
• [23]Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. Bmj 1997, 315(7109):629-34.
• [24]Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovanni G, Lees AJ, et al.: Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012, 72(6):893-901.
• [25]Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ, et al.: Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord 2013, 29(2):195-202.
• [26]Berg D, Marek K, Ross GW, Poewe W: Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 2012, 27(5):656-65.
• [27]Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, et al.: Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 2012, 27(3):406-12.
• [28]Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, et al.: The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 2013, 20(1):102-8.
• [29]Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, et al.: Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol 2014, 21(5):766-72.
• [30]Hawkes CH, Del Tredici K, Braak H: Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci 2009, 1170:615-22.
• [31]Reichmann H: View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication. J Neurol Sci 2011, 310(1–2):9-11.
• [32]Postuma RB, Montplaisir JY, Pelletier A, Dauvilliers Y, Oertel W, Iranzo A, et al.: Environmental risk factors for REM sleep behavior disorder: a multicenter case–control study. Neurology 2012, 79(5):428-34.
• [33]Chen H, Huang X, Guo X, Peddada S: Individual and joint prevalence of three nonmotor symptoms of PD in the US general population. Mov Disord 2014, 29(10):1316-9.
• [34]Postuma RB, Gagnon JF, Montplaisir JY: REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis 2012, 46(3):553-8.
• [35]Hummel T, Konnerth CG, Rosenheim K, Kobal G: Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001, 110(10):976-81.
• [36]Doty RL, Marcus A, Lee WW: Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996, 106(3 Pt 1):353-6.
• [37]Suares NC, Ford AC: Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011, 106(9):1582-91.
• [38]Volkert J, Schulz H, Harter M, Wlodarczyk O, Andreas S: The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res Rev 2013, 12(1):339-53.
• [39]Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM: Prevalence of olfactory impairment in older adults. Jama 2002, 288(18):2307-12.